The Innovator Growth Accelerated Plus ETF - April (QTAP) seeks to provide accelerated exposure to growth stocks through a defined outcome strategy with specific risk/return parameters. This structured product targets enhanced returns from companies exhibiting strong earnings growth, revenue expansion, and innovative business models while incorporating downside protection mechanisms.
How It Works
QTAP employs a defined outcome approach using options strategies to create leveraged exposure to growth equities over a specific outcome period ending in April. The fund combines long equity positions in high-growth companies with options overlays to amplify upside participation while establishing downside buffers. Holdings focus on companies with accelerating earnings growth, expanding profit margins, and disruptive technologies. The structured approach resets annually in April, establishing new risk/return parameters for the following 12-month period.
Key Features
- Defined outcome structure provides predetermined upside participation rates and downside protection levels reset annually each April
- Targets accelerated growth exposure through companies with expanding earnings, revenue growth exceeding 15% annually, and innovative market positions
- Zero expense ratio reduces drag on returns, though underlying options strategies may involve implicit costs through bid-ask spreads
Risks
- This ETF can lose value if growth stocks underperform or if the options overlay fails to provide expected acceleration, potentially limiting gains during strong markets
- Defined outcome structure caps maximum returns at predetermined levels, meaning investors miss gains beyond the participation rate during exceptional growth periods
- Complex options strategies create tracking error versus simple growth stock exposure, with potential for unexpected outcomes if market conditions change dramatically mid-cycle
Who Should Own This
Best suited for tactical allocation (5-15% of portfolio) by investors with medium-to-high risk tolerance seeking enhanced growth exposure over 1-year holding periods. Requires understanding of structured products and defined outcome strategies. Appropriate for investors wanting growth acceleration with some downside mitigation, though not suitable as core equity holding.